Research map: Biomarkers of metastatic disease in pheochromocytoma and paraganglioma

Back to the article

Papers in this map

  1. The Immune Landscape of Cancer · Vésteinn Thórsson · 2018 · 6334 citations · Cited by this paper
  2. 11-deoxycortisol, other hormones and pituitary function characteristics in the diagnosis of adrenal insufficiency in the overnight oral metyrapone test · 2026 · Related
  3. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma · Lauren Michelle Fishbein · 2017 · 807 citations · Cited by this paper
  4. Exploring the relationship between microplastic exposure and bone health · 2026 · Related
  5. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms · Lester D.�R. Thompson · 2002 · 718 citations · Cited by this paper
  6. Mapping transition of care for rare endocrine conditions: findings from a cross-sectional survey by the Endo-ERN ToC Working Group · 2026 · Related
  7. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis · Francien H. van Nederveen · 2009 · 540 citations · Cited by this paper
  8. The Extragonadal Biology of Gonadotropin Hormones –– Should We Rename These? · 2026 · Related
  9. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma · Pierre Francois Plouin · 2016 · 481 citations · Cited by this paper
  10. Group education improves self-management of adrenal insufficiency in patients and their relative · 2026 · Related
  11. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours · Alfred King-yin Lam · 2017 · 465 citations · Cited by this paper
  12. Phosphate handling as a determinant of osteoporosis in primary hyperparathyroidism · 2026 · Related
  13. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas · Özgür Mete · 2022 · 426 citations · Cited by this paper
  14. Mitochondrial gene expression-based model for the prediction of thyroid cancer prognosis · 2026 · Related
  15. SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia · Zhengping Zhuang · 2012 · 402 citations · Cited by this paper
  16. Preconception thyroid function optimization and pregnancy outcomes in women with recurrent pregnancy loss: a real-world cohort study · 2026 · Related
  17. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma · Noriko Kimura · 2014 · 394 citations · Cited by this paper
  18. A quantum approach to the endocrinology of obesity · 2026 · Related
  19. MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma · Nelly Burnichon · 2012 · 337 citations · Cited by this paper
  20. The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic Disease · 2024 · Related
  21. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification · Joakim Crona · 2017 · 324 citations · Cited by this paper
  22. Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography · Henri J L M Timmers · 2012 · 283 citations · Cited by this paper
  23. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review · Annika M. A. Berends · 2018 · 258 citations · Cited by this paper
  24. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention · Birke Bausch · 2017 · 202 citations · Cited by this paper
  25. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma · Sylvie Job · 2018 · 135 citations · Cited by this paper
  26. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta‐analysis · Oksana Hamidi · 2017 · 117 citations · Cited by this paper
  27. Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years · Abdul Rahman Al Subhi · 2022 · 117 citations · Cited by this paper
  28. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma · Jung‐Min Koh · 2017 · 115 citations · Cited by this paper
  29. Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma · Bruna Calsina · 2023 · 106 citations · Cited by this paper
  30. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems · Heather Wachtel · 2020 · 103 citations · Cited by this paper
  31. Mosaicism inHIF2A-Related Polycythemia-Paraganglioma Syndrome · Alexandre Buffet · 2013 · 96 citations · Cited by this paper
  32. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets · Goswin Yason Meyer-Rochow · 2010 · 86 citations · Cited by this paper
  33. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas · Charlie Pierre · 2019 · 82 citations · Cited by this paper
  34. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma · Bruna Calsina · 2019 · 71 citations · Cited by this paper
  35. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDH x Mutations in Paraganglioma · Charlotte Lussey‐Lepoutre · 2015 · 69 citations · Cited by this paper
  36. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma · E Patterson · 2012 · 65 citations · Cited by this paper
  37. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry · C. Christofer Juhlin · 2021 · 65 citations · Cited by this paper
  38. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance · Jan Calissendorff · 2022 · 61 citations · Cited by this paper
  39. MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy · Péter Igaz · 2014 · 53 citations · Cited by this paper

Source: OpenAlex (CC0)